Trans American Aquaculture disclosed that its 2024 annual report can no longer be relied upon due to material errors in liability classifications, accrued interest, and depreciation, and it identified material weaknesses in its internal controls.
Lisata Therapeutics amended its merger agreement with Kuva Labs to extend the deadline for completing the deal from July 17 to July 21, 2026, providing a brief window to finalize the pending acquisition.
Organon voluntarily added disclosures to its definitive proxy statement after a stockholder filed a lawsuit seeking to halt the July 23 special meeting vote on the company's acquisition by Sun Pharma.
River Financial Corporation reported that two additional class action lawsuits have been filed against the company in connection with the June ransomware attack, bringing the total to four.
Arbutus Biopharma received its $178 million share of Moderna’s $950 million patent settlement payment and disclosed performance bonuses for its CEO and CFO tied to litigation proceeds.
ArcBest disclosed a restructuring plan that includes a 2% workforce reduction, the retirement of the MoLo and Panther brand names, facility consolidations, and the discontinuation of its Vaux Freight Movement System. The company expects approximately $85 million in total impairment charges and $40 million in annualized run-rate cash savings.
FirstCash Holdings increased its recommended cash offer for UK-based Ramsdens Holdings to 684 pence per share, up from the original 609 pence, valuing the pawnbroker and financial services company at approximately 229 million pounds sterling.
The bankruptcy court confirmed Inotiv's prepackaged Chapter 11 plan, which will cancel all existing common shares without any distribution to current equity holders and issue new equity to prepetition lenders and noteholders upon emergence as a private company.
Uber has entered into a definitive agreement to acquire Delivery Hero SE through a voluntary public takeover offer at €41.50 per share, valuing the transaction at approximately €14.2 billion and signaling a major expansion of its global delivery footprint.
BayFirst Financial will restate its financial statements for 2024, 2025, and the first quarter of 2026 after discovering misstatements tied to deferred origination costs and accrued interest on defaulted loans, alongside a $37 million asset resolution adjustment.
Record Alpha uses automated systems to identify and summarize public filings, court records, and regulatory actions as they become available. Every article links directly to the primary source document so readers can verify details firsthand. This content is for informational purposes only and is not investment, legal, or financial advice. Full disclaimer →
© 2026 Record Alpha. All rights reserved.